= 0.710, P < 0.001) on admission in acute/subacute CVT patients. In CVT patients, venous infarction was associated with BBB disruption and potentially inflammation. Hs-CRP might serve as a biomarker reflecting the clinical severity of CVT in the acute/subacute stages.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: